TY - JOUR AU - Forbes, S. A. AU - Beare, D. AU - Gunasekaran, P. AU - Leung, K. AU - Bindal, N. AU - Boutselakis, H. PY - 2015 DA - 2015// TI - COSMIC: exploring the world’s knowledge of somatic mutations in human cancer JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gku1075 DO - 10.1093/nar/gku1075 ID - Forbes2015 ER - TY - STD TI - My Cancer Genome. Vanderbilt-Ingram Cancer Center. http://www.mycancergenome.org. Accessed 20 Oct 2015. UR - http://www.mycancergenome.org/ ID - ref2 ER - TY - JOUR AU - Gray, K. A. AU - Yates, B. AU - Seal, R. L. AU - Wright, M. W. AU - Bruford, E. A. PY - 2015 DA - 2015// TI - Genenames.org: the HGNC resources in JO - Nucleic Acids Res 2015 VL - 43 UR - https://doi.org/10.1093/nar/gku1071 DO - 10.1093/nar/gku1071 ID - Gray2015 ER - TY - JOUR AU - Dunnen, J. T. AU - Antonarakis, S. E. PY - 2000 DA - 2000// TI - Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion JO - Hum Mutat VL - 15 UR - https://doi.org/3.0.CO;2-N DO - 3.0.CO;2-N ID - Dunnen2000 ER - TY - JOUR AU - Yuan, Y. AU - Allen, E. M. AU - Omberg, L. AU - Wagle, N. AU - Amin-Mansour, A. AU - Sokolov, A. PY - 2014 DA - 2014// TI - Assessing the clinical utility of cancer genomic and proteomic data across tumor types JO - Nat Biotechnol VL - 32 UR - https://doi.org/10.1038/nbt.2940 DO - 10.1038/nbt.2940 ID - Yuan2014 ER - TY - JOUR AU - Ananda, G. AU - Mockus, S. AU - Lundquist, M. AU - Spotlow, V. AU - Simons, A. AU - Mitchell, T. PY - 2015 DA - 2015// TI - Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors JO - Exp Mol Pathol VL - 98 UR - https://doi.org/10.1016/j.yexmp.2014.12.009 DO - 10.1016/j.yexmp.2014.12.009 ID - Ananda2015 ER - TY - JOUR AU - Schriml, L. M. AU - Mitraka, E. PY - 2015 DA - 2015// TI - The Disease Ontology: fostering interoperability between biological and clinical human disease-related data JO - Mamm Genome Off J Int Mamm Genome Soc VL - 26 UR - https://doi.org/10.1007/s00335-015-9576-9 DO - 10.1007/s00335-015-9576-9 ID - Schriml2015 ER - TY - STD TI - Mockus S, Patterson S, Statz C, Bult C, Tsongalis G. Clinical trials in precision oncology. Clin Chem. 2015.247437. [Epub ahead of print] ID - ref8 ER - TY - JOUR AU - Roper, N. AU - Stensland, K. D. AU - Hendricks, R. AU - Galsky, M. D. PY - 2015 DA - 2015// TI - The landscape of precision cancer medicine clinical trials in the United States JO - Cancer Treat Rev VL - 41 UR - https://doi.org/10.1016/j.ctrv.2015.02.009 DO - 10.1016/j.ctrv.2015.02.009 ID - Roper2015 ER - TY - JOUR AU - Maio, S. AU - Yip, S. AU - Al Zhrani, G. A. AU - Alotaibi, F. E. AU - Al Turki, A. AU - Kong, E. PY - 2015 DA - 2015// TI - Novel targeted therapies in chordoma: an update JO - Ther Clin Risk Manag VL - 11 UR - https://doi.org/10.2147/TCRM.S50526 DO - 10.2147/TCRM.S50526 ID - Maio2015 ER - TY - JOUR AU - Ramakrishna, R. AU - Rostomily, R. AU - Sekhar, L. AU - Rockhill, J. AU - Ferreira, M. PY - 2014 DA - 2014// TI - Hemangiopericytoma: radical resection remains the cornerstone of therapy JO - J Clin Neurosci Off J Neurosurg Soc Australas VL - 21 ID - Ramakrishna2014 ER - TY - JOUR AU - Sana, M. AU - Malik, H. J. PY - 2015 DA - 2015// TI - Current and emerging breast cancer biomarkers JO - J Cancer Res Ther VL - 11 UR - https://doi.org/10.4103/0973-1482.163698 DO - 10.4103/0973-1482.163698 ID - Sana2015 ER - TY - JOUR AU - Spagnolo, F. AU - Ghiorzo, P. AU - Orgiano, L. AU - Pastorino, L. AU - Picasso, V. AU - Tornari, E. PY - 2015 DA - 2015// TI - BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies JO - OncoTargets Ther VL - 8 UR - https://doi.org/10.2147/OTT.S39096 DO - 10.2147/OTT.S39096 ID - Spagnolo2015 ER - TY - STD TI - Kuan F-C, Kuo L-T, Chen M-C, Yang C-T, Shi C-S, Teng D, et al. Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis. Br J Cancer. 2015;113(10):1519-28. ID - ref14 ER - TY - STD TI - Naidoo J, Sima CS, Rodriguez K, Busby N, Nafa K, Ladanyi M, et al. Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib. Cancer. 2015;121(18):3212-20. ID - ref15 ER - TY - JOUR AU - Yasuda, H. AU - Park, E. AU - Yun, C. -. H. AU - Sng, N. J. AU - Lucena-Araujo, A. R. AU - Yeo, W. -. L. PY - 2013 DA - 2013// TI - Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3007205 DO - 10.1126/scitranslmed.3007205 ID - Yasuda2013 ER - TY - JOUR AU - Choi, Y. J. AU - Kim, S. Y. AU - So, K. S. AU - Baek, I. -. J. AU - Kim, W. S. AU - Choi, S. H. PY - 2015 DA - 2015// TI - AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cells JO - PloS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0119832 DO - 10.1371/journal.pone.0119832 ID - Choi2015 ER - TY - JOUR AU - Brown, G. R. AU - Hem, V. AU - Katz, K. S. AU - Ovetsky, M. AU - Wallin, C. AU - Ermolaeva, O. PY - 2015 DA - 2015// TI - Gene: a gene-centered information resource at NCBI JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gku1055 DO - 10.1093/nar/gku1055 ID - Brown2015 ER - TY - JOUR AU - Petri, V. AU - Jayaraman, P. AU - Tutaj, M. AU - Hayman, G. T. AU - Smith, J. R. AU - Pons, J. PY - 2014 DA - 2014// TI - The pathway ontology—updates and applications JO - J Biomed Semant VL - 5 UR - https://doi.org/10.1186/2041-1480-5-7 DO - 10.1186/2041-1480-5-7 ID - Petri2014 ER - TY - JOUR AU - Costa, D. B. AU - Nguyen, K. -. S. H. AU - Cho, B. C. AU - Sequist, L. V. AU - Jackman, D. M. AU - Riely, G. J. PY - 2008 DA - 2008// TI - Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib JO - Clin Cancer Res Off J Am Assoc Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-1455 DO - 10.1158/1078-0432.CCR-08-1455 ID - Costa2008 ER - TY - JOUR AU - Robinson, K. W. AU - Sandler, A. B. PY - 2013 DA - 2013// TI - The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agents JO - The Oncologist VL - 18 UR - https://doi.org/10.1634/theoncologist.2012-0262 DO - 10.1634/theoncologist.2012-0262 ID - Robinson2013 ER - TY - JOUR AU - Turke, A. B. AU - Zejnullahu, K. AU - Wu, Y. -. L. AU - Song, Y. AU - Dias-Santagata, D. AU - Lifshits, E. PY - 2010 DA - 2010// TI - Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC JO - Cancer Cell VL - 17 UR - https://doi.org/10.1016/j.ccr.2009.11.022 DO - 10.1016/j.ccr.2009.11.022 ID - Turke2010 ER - TY - STD TI - Mancini M, Yarden Y. Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors. Semin Cell Dev Biol. 2015;pii: S1084-9521(15)00178-0. [Epub ahead of print]. ID - ref23 ER - TY - JOUR AU - Gymnopoulos, M. AU - Elsliger, M. -. A. AU - Vogt, P. K. PY - 2007 DA - 2007// TI - Rare cancer-specific mutations in PIK3CA show gain of function JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0701005104 DO - 10.1073/pnas.0701005104 ID - Gymnopoulos2007 ER -